Literature DB >> 15062361

Current treatment options in squamous cell carcinoma of the oral cavity.

Carsten E Palme1, Patrick J Gullane, Ralph W Gilbert.   

Abstract

Oral cavity SCC remains a significant health problem and requires a multidisciplinary approach. Treatment with surgery alone or in combination with adjuvant radiotherapy for more advanced lesions is the standard of care. Major advances have been made in surgical approaches,reconstructive options, and the rehabilitation of patients who have oral cavity SCC. These advances have significantly improved disease-specific outcome and quality of life. The future may lie in the development of treatment regimes that combine early detection with organ preservation and result in improved cure rates and quality of life.

Entities:  

Mesh:

Year:  2004        PMID: 15062361     DOI: 10.1016/S1055-3207(03)00123-6

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  12 in total

1.  Head and neck tumor cell radiation response occurs in the presence of IGF1.

Authors:  K Victory; R Burd; A Fribley; S Sittadjody; D Arnett; R R Klein; K H Limesand
Journal:  J Dent Res       Date:  2010-11-12       Impact factor: 6.116

2.  Oral tongue carcinoma and its treatment in Finland.

Authors:  Antti A Mäkitie; Petri Koivunen; Harri Keski-Säntti; Jyrki Törnwall; Matti Pukkila; Jussi Laranne; Marjaana Luukkaa; Jyrki Vuola; Timo Joensuu; Mikael Kajanti; Reidar Grénman
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-09-21       Impact factor: 2.503

3.  Over-expression of Gadd45a enhances radiotherapy efficacy in human Tca8113 cell line.

Authors:  Xiao-ying Zhang; Xun Qu; Cheng-qin Wang; Cheng-jun Zhou; Gui-xiang Liu; Feng-cai Wei; Shan-zhen Sun
Journal:  Acta Pharmacol Sin       Date:  2011-02       Impact factor: 6.150

4.  Impact of a second FDG PET scan before adjuvant therapy for the early detection of residual/relapsing tumours in high-risk patients with oral cavity cancer and pathological extracapsular spread.

Authors:  Chun-Ta Liao; Kang-Hsing Fan; Chien-Yu Lin; Hung-Ming Wang; Shiang-Fu Huang; I-How Chen; Chung-Jan Kang; Shu-Hang Ng; Chuen Hsueh; Li-Yu Lee; Chih-Hung Lin; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-03-21       Impact factor: 9.236

Review 5.  Histone modifications: Targeting head and neck cancer stem cells.

Authors:  John M Le; Cristiane H Squarize; Rogerio M Castilho
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

6.  Systemic lupus erythematosus, pregnancy and carcinoma of the tongue.

Authors:  Jeffrey David Unsworth; Andrew Baldwin; Louise Byrd
Journal:  BMJ Case Rep       Date:  2013-05-31

7.  Role of high dose rate interstitial brachytherapy in early and locally advanced squamous cell carcinoma of buccal mucosa.

Authors:  Parthasarathy Vedasoundaram; Aravind Kumar Prasanna; Reddy Ks; Gangothri Selvarajan; Mourougan Sinnatamby; Seenisamy Ramapandian; Saravanan Kandasamy
Journal:  Springerplus       Date:  2014-10-09

8.  Tumor budding and adjacent tissue at the invasive front correlate with delayed neck metastasis in clinical early-stage tongue squamous cell carcinoma.

Authors:  Nobuhiro Yamakawa; Tadaaki Kirita; Masahiro Umeda; Souichi Yanamoto; Yoshihide Ota; Mitsunobu Otsuru; Masaya Okura; Hiroshi Kurita; Shin-Ichi Yamada; Takumi Hasegawa; Tomonao Aikawa; Takahide Komori; Michihiro Ueda
Journal:  J Surg Oncol       Date:  2018-12-12       Impact factor: 3.454

9.  Role of p53 mutation in the effect of boron neutron capture therapy on oral squamous cell carcinoma.

Authors:  Yusei Fujita; Itsuro Kato; Soichi Iwai; Koji Ono; Minoru Suzuki; Yoshinori Sakurai; Ken Ohnishi; Takeo Ohnishi; Yoshiaki Yura
Journal:  Radiat Oncol       Date:  2009-12-11       Impact factor: 3.481

10.  Intra-arterial chemoradiation for T3-4 oral cavity cancer: treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma.

Authors:  Ilana Doweck; K Thomas Robbins; Sandeep Samant; Francisco Vieira
Journal:  World J Surg Oncol       Date:  2008-01-14       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.